Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) — Free Cash Flow Generation Index
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a Free Cash Flow Generation Index of 0.87x as of March 2026. Free cash flow of TL156.37 Million represents 1% of operating cash flow (TL180.45 Million). Read total liabilities of Meditera Tibbi Malzeme Sanayi ve Ticaret for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Free Cash Flow Generation Index (2018–2025)
Historical FCF Generation Index trend for Meditera Tibbi Malzeme Sanayi ve Ticaret AS across 8 annual periods. Explore MEDTR capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2018–2025)
Year-by-year Free Cash Flow Generation Index for Meditera Tibbi Malzeme Sanayi ve Ticaret AS. For the full company profile including market capitalisation, see Meditera Tibbi Malzeme Sanayi ve Ticaret (MEDTR) market capitalisation.
| Year | FCG Index | Free Cash Flow (TRY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.56x | TL243.68 Million | TL435.35 Million | TL191.67 Million | ▼ -15.5% |
| 2024 | 0.66x | TL517.17 Million | TL780.69 Million | TL263.52 Million | ▲ +5.8% |
| 2023 | 0.63x | TL501.32 Million | TL801.02 Million | TL299.70 Million | ▲ +106.8% |
| 2022 | -9.19x | TL-46.87 Million | TL5.10 Million | TL51.35 Million | ▼ -1328.3% |
| 2021 | 0.75x | TL27.42 Million | TL36.64 Million | TL8.92 Million | ▲ +73.2% |
| 2020 | 0.43x | TL31.65 Million | TL73.26 Million | TL20.85 Million | ▼ -56.8% |
| 2019 | 1.00x | TL20.01 Million | TL20.01 Million | TL0.00 | ▲ +0.0% |
| 2018 | 1.00x | TL73.26 Million | TL73.26 Million | TL0.00 | — |